Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.
Grandclément C. et al, (2024), Nat commun, 15
The integrated on-chip isolation and detection of circulating tumour cells
Abusamra SM. et al, (2024), Sensors & diagnostics
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.
Pouleau B. et al, (2023), Blood, 142, 260 - 273
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10.
Richter FC. et al, (2023), Embo j
Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers.
Agarwal G. et al, (2022), Cancers (basel), 15
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease.
Leng H. et al, (2022), Nat commun, 13
Multiple myeloma metabolism – a treasure trove of therapeutic targets?
Roman-Trufero M. et al, (2022), Frontiers in immunology, 13
Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival.
Whitburn J. et al, (2022), Sci adv, 8
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
Gámez B. et al, (2022), Translational oncology, 15, 101301 - 101301
Adipocyte autophagy limits gut inflammation by controlling oxylipin levels
Richter FC. et al, (2021)
Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations.
Brown JE. et al, (2021), J bone oncol, 29
Myeloma and marrow adiposity: Unanswered questions and future directions.
Morris EV. and Edwards CM., (2021), Best pract res clin endocrinol metab, 35
Advances in the molecular pharmacology of bone and cancer-related bone diseases.
Edwards CM. and Russell RGG., (2021), Br j pharmacol, 178, 1889 - 1890
Morphogens and growth factor signalling in the myeloma bone-lining niche.
Morris EV. and Edwards CM., (2021), Cell mol life sci
Biological relationship between bone and myeloma cells
Edwards CM. and Lawson MA., (2021), Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside, 1005 - 1017
Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha.
Morris EV. et al, (2020), J bone miner res, 35, 942 - 955
Modeling the Human Bone-Tumor Niche: Reducing and Replacing the Need for Animal Data.
Rao SR. et al, (2020), Jbmr plus, 4
Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer Metastasis.
Rao SR. et al, (2020), Front oncol, 10